Antiplatelet agent vs control
Death (any cause) · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
Antiplatelet agents showed no clear difference in death (any cause) compared with control (low certainty).
1 finding from 1 review
- RR 0.94 [0.84, 1.06]35 studies · 18241 participantsLow